JEANNIE UMANZOR: Open Payments
NPI 1992234165 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,624 in 52 payments from 7 companies in 2025. Trend: 2023 $871 · 2024 $6,283 · 2025 $9,624
Speaker / faculty: $8,809Food & beverage: $704Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $5,845 |
| Teva Pharmaceuticals USA, Inc. | 16 | $3,325 |
| Lundbeck LLC | 17 | $188 |
| ViiV Healthcare Company | 1 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| ABBVIE INC. | 2 | $44 |
| Indivior Inc. | 1 | $35 |
Products named: ABILIFY MAINTENA, UZEDY, ABILIFY ASIMTUFII, CAPLYTA, MAVYRET, SUBLOCADE, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
